Aerobic vs Resistance Exercise in Post-menopausal Women With Type 1 Diabetes
NCT05188027
Summary
Participants will be asked to wear a continuous glucose monitor for at least three days on three separate occasions. One testing session will be a no-exercise resting control session (90 minutes). One will be a moderate aerobic exercise session (30 minutes of exercise, 60 minutes of recovery), and the third will be a moderate weight-lifting session (\~30 minutes of exercise, 60 minutes of recovery).The investigators will measure changes in blood glucose during exercise by drawing blood during and after exercise. Post-exercise glucose trends will be examined using continuous glucose monitoring.
Eligibility
Inclusion Criteria: * type 1 diabetes, diagnosed for at least one year * post-menopause (at least one year since last menstrual period), or have had a hysterectomy and bilateral salpingo oophorectomy * able to perform aerobic and resistance exercise * able to visit the lab in Edmonton, Alberta (University of Alberta) Exclusion Criteria: * HbA1c \> 9.9 % * frequent and unpredictable hypoglycemia * change in insulin management strategy within the last 2 months * blood pressure \> 140 / 95 * severe peripheral neuropathy * history of cardiovascular disease * musculoskeletal injuries interfering with exercise performance * use of medications (other than insulin) that affect glucose metabolism * BMI \> 30 kg/m2 * smoking * moderate to high alcohol intake (\> 2 drinks/day)
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05188027